Funded Tech Companies

invIOs

invIOs, based in Vienna, received equity investments through Ligand Pharmaceuticals and private investors.

Company Overview

Company Name
invIOs
Company Status
Private & Independent
Industry
Funding Rounds

Contact Information

Mailing Address
Campus-Vienna-Biocenter 5
Vienna, 1030
Austria
Email Address

Company Background Information

Overview
invIOs is a PRIVATE BIOTECH COMPANY focusing on discovering and developing next-generation cancer therapeutics. We are pioneers in R&D of drug candidates targeting novel immune checkpoints, and in IMMUNE SYSTEM ACTIVATION. We LAUNCHED IN 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics.
Profile
invIOs LinkedIn Company Profile
Social Media
invIOs Company Twitter Account
Company News
invIOs News
Facebook
invIOs on Facebook
YouTube
invIOs on YouTube
Last Transaction
10/15/2024

Financing History

Date
Type
Amount
Venture Equity
$8,900,000


Management Team

Title
Name
Email & Social
Chairman
Manfred Reichl
  Manfred Reichl LinkedIn Profile  Manfred Reichl Twitter Account  Manfred Reichl News  Manfred Reichl on Facebook
Chief Executive Officer
Peter Llewellyn-Davies
  Peter Llewellyn-Davies LinkedIn Profile  Peter Llewellyn-Davies Twitter Account  Peter Llewellyn-Davies News  Peter Llewellyn-Davies on Facebook
Chief Scientific Officer
Romana Gugenberger
  Romana Gugenberger LinkedIn Profile  Romana Gugenberger Twitter Account  Romana Gugenberger News  Romana Gugenberger on Facebook


Company Investors

  • Ligand Pharmaceuticals

 

 

 

Browse more funded tech companies:

invino | Inviragen

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary